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Background: Patients with STEMI and impaired renal function are a high risk population.
Methods: Between Oct 2006 and Oct 2008, 21,582 consecutive patients with ACS were enrolled into the ACS-Registry of the Euro Heart Survey 
Programme to document patient characteristics, treatment and hospital complications. We examined the impact of impaired renal function 
(GFR<60ml/min, Cockroft-Gault formula) on treatment and hospital outcome in patients with STEMI in clinical practice.
Results: Out of 21,872 patients with ACS, 8854 presented with STEMI. In 7,523 patients serum creatinine was documented. A total of 2,046 
patients with STEMI (27 %) had GFR <60ml/min. These patients were 13 years older and had a higher prevalence of concomitant diseases. Patients 
with GFR<60ml/min less often received primary PCI as well as medical adjunctive therapy as compared to patients with normal renal function. 
STEMI-patients with GFR<60ml/min had a significant higher hospital mortality even after correction for the marked differences in age, in baseline 
characteristics and in acute treatment (OR 2.53, 95% CI 2.01-3.17).
Conclusion: Despite the recognition of STEMI patients with impaired renal function as a high risk population, patients with GFR<60ml/min less 
often underwent acute reperfusion treatment and less often received acute adjunctive medical treatment. GFR<60ml/min was an independent 
prognostic factor in STEMI with a more than a 2.5-fold increased risk for hospital mortality in clinical practice. 
GFR<60ml/min
n=2046
GFR>=60ml/min
n=5477
p-value
Age [years] 73 60 <0.01
Female Gender 45.2 % 21.7 % <0.01
Prior MI 19.3 % 12.9 % <0.01
Prior PCI 9.5 % 7.9 % =0.02
Diabetes mellitus 31.2 % 19.7 % <0.01
3-Vessel-Disease 28.4 % 19.4 % <0.01
Primary PCI 60.2 % 74.4 % <0.01
GP IIb/IIIa 26.1 % 36.2 % <0.01
ASA 95.1 % 97.3 % <0.01
Clopidogrel 82.9 % 89.7 % <0.01
LMW-Heparin 39.3 % 44.0 % <0.01
Hospital Mortality 16.1 % 3.3 % <0.01
